Is laboratory monitoring of low-molecular-weight heparin therapy necessary? No

J Thromb Haemost. 2004 Apr;2(4):551-4. doi: 10.1111/j.1538-7933.2004.00648.x.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anticoagulants / adverse effects
  • Anticoagulants / blood
  • Anticoagulants / therapeutic use
  • Drug Monitoring*
  • Hemorrhage / etiology
  • Hemorrhage / prevention & control
  • Heparin, Low-Molecular-Weight / adverse effects
  • Heparin, Low-Molecular-Weight / blood
  • Heparin, Low-Molecular-Weight / therapeutic use*
  • Humans
  • Partial Thromboplastin Time
  • Practice Guidelines as Topic
  • Risk
  • Thromboembolism / etiology

Substances

  • Anticoagulants
  • Heparin, Low-Molecular-Weight